Literature DB >> 29705352

Apigenin-7-O-β-d-(-6″-p-coumaroyl)-glucopyranoside pretreatment attenuates myocardial ischemia/reperfusion injury via activating AMPK signaling.

Yingda Feng1, Yunyang Lu2, Dan Liu3, Wei Zhang4, Juntian Liu5, Haifeng Tang6, Yanrong Zhu7.   

Abstract

AIMS: Apigenin-7-O-β-d-(-6″-p-coumaroyl)-glucopyranoside (APG) was considered as the major active compound derived from Clematis tangutica. Though we have demonstrated that APG exerts cardioprotective effects, the mechanism of APG-mediated cardioprotection remains largely unknown. Numerous studies indicate that endoplasmic reticulum stress (ERS) is a vital injury factor in myocardial ischemia reperfusion (MI/R). In this study, we mainly investigated whether modulation of the ERS and AMPK were involved in the cardioprotective action of APG during MI/R injury. MAIN
METHODS: The perfused isolated rat heart or primary neonatal rat cardiomyocytes which exposed to APG with or else without the AMPK inhibitor Compound C was then subject to MI/R. After reperfusion, the degree of myocardial injury was assessed by using lactate dehydrogenase (LDH) release, creatine kinase (CK) release, histological examination, and TTC staining. The protein expressions of p-AMPK, AMPK, p-PERK, PERK, p-eIF2α, eIF2α, CHOP, Bax, Bcl2 and Cleaved Caspase 3 were analyzed by western blot. The cell viability was assessed by CCK-8 kit while apoptosis assessed by using TUNEL assay. KEY
FINDINGS: Pretreatment of APG significantly improved cardiac function and suppressed ERS through activating the AMPK signaling pathway, which could simultaneously improve cardiac function, alleviate myocardial injury, increase the cell viability and decrease apoptosis. SIGNIFICANCE: To conclude, APG ameliorates MI/R injury by activating the AMPK signaling pathway and relieving endoplasmic reticulum stress. APG may be a natural product with pharmacological preconditioning activity, which could do us a favor to develop more novel therapy methods to against MI/R injury in the future.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AMPK; APG; Apoptosis; ERS; Myocardial ischemia/reperfusion injury

Mesh:

Substances:

Year:  2018        PMID: 29705352     DOI: 10.1016/j.lfs.2018.04.048

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  Galanthamine improves myocardial ischemia-reperfusion-induced cardiac dysfunction, endoplasmic reticulum stress-related apoptosis, and myocardial fibrosis by suppressing AMPK/Nrf2 pathway in rats.

Authors:  Xiaolin Hou; Minhuan Fu; Biao Cheng; Yu Kang; Dili Xie
Journal:  Ann Transl Med       Date:  2019-11

2.  Clinical Prescription-Protein-Small Molecule-Disease Strategy (CPSD), A New Strategy for Chinese Medicine Development: A Case Study in Cardiovascular Diseases.

Authors:  Yong-Zhi Guo; Ying-Nan Jiang; Yi-Fang Li; Hiroshi Kurihara; Yi Dai; Rong-Rong He
Journal:  Front Pharmacol       Date:  2020-01-22       Impact factor: 5.810

3.  Effects of Apigenin Treatment on Random Skin Flap Survival in Rats.

Authors:  Xinyi Ma; Yuting Lin; Yingying Liu; Wenjie Li; Jibing He; Miaojie Fang; Dingsheng Lin
Journal:  Front Pharmacol       Date:  2021-02-24       Impact factor: 5.810

Review 4.  Hematogenous Macrophages: A New Therapeutic Target for Spinal Cord Injury.

Authors:  Yuanzhe Ding; Di Zhang; Sheng Wang; Xiaolei Zhang; Jingquan Yang
Journal:  Front Cell Dev Biol       Date:  2021-11-24

5.  APPL1 ameliorates myocardial ischemia-reperfusion injury by regulating the AMPK signaling pathway.

Authors:  Yunguang Cen; Wei Liao; Taihao Wang; Daimin Zhang
Journal:  Exp Ther Med       Date:  2021-12-17       Impact factor: 2.447

Review 6.  The New Role of AMP-Activated Protein Kinase in Regulating Fat Metabolism and Energy Expenditure in Adipose Tissue.

Authors:  Qun Wang; Jiayi Sun; Mengyu Liu; Yaqi Zhou; Lei Zhang; Yanzhang Li
Journal:  Biomolecules       Date:  2021-11-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.